Literature DB >> 9723646

Role of platelet glycoprotein PL(A1/A2) polymorphism in restenosis after percutaneous transluminal coronary angioplasty.

R Abbate1, R Marcucci, O Camacho-Vanegas, G Pepe, A M Gori, M Capanni, I Simonetti, D Prisco, G F Gensini.   

Abstract

This study suggests a macroheterogeneity in prevalence of platelet glycoprotein PL(A1/A2) polymorphism in different ethnic populations. In patients undergoing percutaneous transluminal coronary angioplasty, this polymorphism does not represent an independent risk factor but seems to be implicated in restenosis after percutaneous transluminal coronary angioplasty.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9723646     DOI： 10.1016/s0002-9149(98)00379-8

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN： 0002-9149            Impact factor:   2.778


  5 in total

Review 1.  Platelet PlA2 polymorphism and thromboembolic events: from inherited risk to pharmacogenetics.

Authors:  P J Goldschmidt-Clermont; C M Roos; G E Cooke
Journal:  J Thromb Thrombolysis       Date:  1999-08       Impact factor: 2.300

Review 2.  Role of platelet glycoprotein polymorphisms in cardiovascular diseases.

Authors:  Christian Meisel; José A López; Karl Stangl
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2003-11-12       Impact factor: 3.000

Review 3.  Genetic risk factors and restenosis after percutaneous coronary interventions.

Authors:  A Kastrati; J Dirschinger; A Schömig
Journal:  Herz       Date:  2000-02       Impact factor: 1.443

4.  Interleukin 1 receptor antagonist gene polymorphism and restenosis after coronary angioplasty.

Authors:  S E Francis; N J Camp; A J Burton; R M Dewberry; J Gunn; A Stephens-Lloyd; D C Cumberland; A Gershlick; D C Crossman
Journal:  Heart       Date:  2001-09       Impact factor: 5.994

5.  Investigation on genetic thrombophilic factors in FFPE autopsy tissue from subjects who died from pulmonary embolism.

Authors:  Francesco Brandimarti; Federica Alessandrini; Mauro Pesaresi; Chiara Catalani; Letizia De Angelis; Roberta Galeazzi; Simona Giovagnetti; Rosaria Gesuita; Elisa Righi; Raffaele Giorgetti; Adriano Tagliabracci
Journal:  Int J Legal Med       Date:  2016-12-09       Impact factor: 2.686
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.